Literature DB >> 14729221

Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats.

K Schwabe1, M Koch.   

Abstract

The medial prefrontal cortex (mPFC) regulates sensorimotor gating measured as prepulse inhibition (PPI) of startle. We here tested the effect of lesions of the mPFC on the PPI-disruptive effect of the non-competitive NMDA receptor antagonist dizocilpine in rats. Neurotoxic lesions of the mPFC were induced by ibotenic acid. Rats were tested for PPI after systemic injection of dizocilpine (0.15 mg/kg) and after injection of the dopamine receptor agonist apomorphine (2 mg/kg). Dizocilpine failed to disrupt PPI in rats with mPFC lesions while the PPI-disruptive effect of apomorphine was not affected. Startle response magnitude in the absence of prepulses was not affected by mPFC lesions or drugs. These data suggest that the mPFC is an important brain region within the neuronal circuit responsible for NMDA receptor antagonist induced PPI-deficits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729221     DOI: 10.1016/j.neulet.2003.10.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.

Authors:  Katarzyna Fijał; Piotr Popik; Agnieszka Nikiforuk
Journal:  Psychopharmacology (Berl)       Date:  2013-08-18       Impact factor: 4.530

2.  Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.

Authors:  Karen M Alsene; Abha K Rajbhandari; Marcia J Ramaker; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

3.  Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.

Authors:  T Notter; J M Coughlin; T Gschwind; U Weber-Stadlbauer; Y Wang; M Kassiou; A C Vernon; D Benke; M G Pomper; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

4.  The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-06-28       Impact factor: 4.530

5.  Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats.

Authors:  J M Shoemaker; R L Saint Marie; M J Bongiovanni; A C Neary; L S Tochen; N R Swerdlow
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatment.

Authors:  Leon G Coleman; L Fredrik Jarskog; Sheryl S Moy; Fulton T Crews
Journal:  Pharmacol Biochem Behav       Date:  2009-05-03       Impact factor: 3.533

8.  Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Tomonori Seo; Hiroko Itoh; Tadasu Matsuoka; Michio Suzuki; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

9.  1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.

Authors:  Małgorzata Pietraszek; Jerzy Michaluk; Irena Romańska; Agnieszka Wasik; Krystyna Gołembiowska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-08-01       Impact factor: 3.911

10.  Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex.

Authors:  Benoit Labonte; Francis Rodriguez Bambico; Gabriella Gobbi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.